Crystagen is primarily recognized for its immunomodulatory effects, helping to normalize immune function by addressing peptide deficiency and restoring protein synthesis in immune cells. It has been shown to normalize the immunogram in 82% of elderly patients when used alongside standard treatment, compared to 56% in controls. The peptide enhances T-cell and B-cell activity, supports thymic integrity, and stimulates immune cell proliferation, which is crucial for robust immune defense.
Studies also indicate that Crystagen increases resistance to respiratory viral infections, particularly in high-stress groups like athletes, and supports recovery after infections, chemotherapy, or radiation exposure.